TELA Bio Expands Presence in Europe with Launch of OviTex Inguinal for Minimally Invasive, Robotic Hernia Repair

Stock Information for TELA Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TELA Bio Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
TELA Bio to Announce Third Quarter 2025 Financial Results
TELA Bio Appoints William Plovanic to Board of Directors
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.